Formula Growth LTD Axogen, Inc. Transaction History

Formula Growth LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$7.35 - $10.81 $294,000 - $432,400	-40,000 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$8.38 - $17.34 $377,100 - $780,300	-45,000 Reduced 52.94%	40,000 $416,000
Q4 2019 Feb 13, 2020	BUY	$11.18 - $18.6 $111,800 - $186,000	10,000 Added 13.33%	85,000 $1.52 Million
Q3 2019 Nov 14, 2019	BUY	$12.09 - $20.46 $241,800 - $409,200	20,000 Added 36.36%	75,000 $936,000
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $185,000 - $254,700	10,000 Added 22.22%	55,000 $1.09 Million
Q1 2019 May 14, 2019	BUY	$14.62 - $22.13 $657,900 - $995,850	45,000 New	45,000 $948,000

180

36.4M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $767M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Formula Growth LTD, based on Form 13F filings with the SEC.

Stay updated on Formula Growth LTD with notifications on news.